These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30455338)

  • 1. Improvement in Neuropathy Outcomes With Normalizing HbA
    Ishibashi F; Taniguchi M; Kosaka A; Uetake H; Tavakoli M
    Diabetes Care; 2019 Jan; 42(1):110-118. PubMed ID: 30455338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study.
    Ishibashi F; Kosaka A; Tavakoli M
    Front Endocrinol (Lausanne); 2022; 13():864332. PubMed ID: 35784562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Normoglycemia in Reducing Microvascular Complications in Patients with Type 2 Diabetes: A Follow-Up Study.
    Ishibashi F; Tavakoli M
    Front Endocrinol (Lausanne); 2018; 9():52. PubMed ID: 29545773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1
    Ma J; He H; Yang X; Chen D; Tan C; Zhong L; Du Q; Wu X; Gao Y; Liu G; Wang C; Ran X
    Nutr Diabetes; 2021 Jun; 11(1):14. PubMed ID: 34088897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.
    ; Gilbert RE; Mann JF; Hanefeld M; Spinas G; Bosch J; Yusuf S; Gerstein HC
    Diabetologia; 2014 Jul; 57(7):1325-31. PubMed ID: 24771090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
    Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
    J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HbA
    Peterson M; Pingel R; Lagali N; Dahlin LB; Rolandsson O
    Diabet Med; 2017 Dec; 34(12):1756-1764. PubMed ID: 28929513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA
    Henry RR; Rosenstock J; Denham DS; Prabhakar P; Kjems L; Baron MA
    Diabetes Care; 2018 Mar; 41(3):613-619. PubMed ID: 29301824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes.
    Azmi S; Ferdousi M; Petropoulos IN; Ponirakis G; Alam U; Fadavi H; Asghar O; Marshall A; Atkinson AJ; Jones W; Boulton AJ; Tavakoli M; Jeziorska M; Malik RA
    Diabetes Care; 2015 Aug; 38(8):1502-8. PubMed ID: 25877814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
    Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.